AIP
CELU icon

Ameritas Investment Partners’s Celularity CELU Stock Holding History

Ameritas Investment Partners’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-528
Closed -$3.27K – 3129
2023
Q1 		$3.27K Hold
528
– – ﹤0.01% 2923
2022
Q4 		$5.54K Hold
528
– – ﹤0.01% 2906
2022
Q3 		$12K Buy
528
+411
+351% +$12.5K ﹤0.01% 2739
2022
Q2 		$3K Buy
+117
New +$9.5K ﹤0.01% 3002

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameritas Investment Partners's CELU Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Celularity (CELU) in Q2 2023, closing a stake of 528 shares — an estimated $3.27K sold.

Ameritas Investment Partners first reported a position in CELU in Q2 2022 and held it in 4 quarters. The position peaked at $12K in Q3 2022. 56 funds tracked by Wall St. Rank hold CELU as of Q2 2023.

  • Ameritas Investment Partners reported no remaining Celularity position as of Q2 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 528 Celularity shares in Q2 2023, an estimated $3.27K.
  • Ameritas Investment Partners first reported a position in Celularity in Q2 2022 and held it in 4 quarters.
  • Ameritas Investment Partners's Celularity position peaked at $12K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Celularity as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.